DESMOPRESSIN ACETATE
These highlights do not include all the information needed to use DESMOPRESSIN ACETATE INJECTION USP safely and effectively. See full prescribing information for DESMOPRESSIN ACETATE INJECTION USP. DESMOPRESSIN ACETATE injection, for intravenous or subcutaneous use Initial U.S. Approval: 1978
Approved
Approval ID
b2fad59d-6176-4e09-9fbb-5cdd7f8f1568
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 16, 2023
Manufacturers
FDA
UBI Pharma Inc.
DUNS: 658871159
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DESMOPRESSIN ACETATE
PRODUCT DETAILS
NDC Product Code72843-459
Application NumberANDA210218
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS, INTRAVENOUS
Effective DateOctober 16, 2023
Generic NameDESMOPRESSIN ACETATE
INGREDIENTS (1)
DESMOPRESSIN ACETATEActive
Quantity: 4 ug in 1 mL
Code: XB13HYU18U
Classification: ACTIB